Trials / Sponsors / Trishula Therapeutics, Inc.
Trishula Therapeutics, Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients Pancreatic Cancer | Phase 2 | 2024-03-25 |
| Completed | TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers Solid Tumor, Adult | Phase 1 | 2020-03-30 |
| Completed | TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers Solid Tumor, Lymphoma | Phase 1 | 2019-04-10 |